Skip to main content

Table 1 Characteristics of study collective

From: Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions

  Mean SD Median Range
Age (years) 71.3 7.5 72 52–82
Days PSMA-PET to MRI 50.2 32.5 42 1–110
PI-RADS score 4.7 0.6 5 3–5
Days GSc to PSMA-PET 74.2 80.2 46 3–299
Gleason score 7.9 1.1 8 6–10
Days PSA to PSMA-PET 16.2 25.6 3 0–84
PSA (ng/ml) 17.7 21.5 11 0.23–116
VTV (cm3) 12.3 11.3 9 0.8–54.1
  1. This table summarizes the main characteristics of the patients investigated in this study. This included the age of the patients, the PI-RADS and Gleason score, PSA blood level, and the viable tumor volume as well as the time difference between PSMA-PET and MRI, between Gleason score and PSMA-PET, between PSA blood level sampling date and PSMA-PET. Data are given in means, standard deviations, medians, and ranges. Abbreviations: GSc Gleason score, PSA prostate-specific antigen blood level, PSMA prostate-specific membrane antigen, PET positron emission tomography, MRI magnetic resonance imaging, PI-RADS prostate imaging reporting and data system, VTV viable tumor volume